ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs
July 01, 2021Kazia Therapeutics Limited, an oncology-focused drug development company, is pleased to provide an update on recent progress with its two pipeline assets, paxalisib and EVT801. -
Evotec Enters Master Service Agreement with Kazia Therapeutics
April 20, 2021Evotec SE has entered into a licensing and master service agreement with Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company.
Pharma Sources Insight January 2025
